Clinical use of an herbal-derived compound (Huperzine A) to treat putative complex partial seizures in a dog

Epilepsy and Behavior

Volumn 15, Issue 4, 2009, Pages 529-534

  Schneider, Barbara M ^a   Dodman, Nicholas H ^a   Faissler, Dominik ^a   Ogata, Niwako ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Complex partial seizures; Dog; Electroencephalography; Huperzine A; Phenobarbital

Indexed keywords

DIPHENHYDRAMINE; HUPERZINE A; PHENOBARBITAL; TRAMADOL;

ABNORMAL BEHAVIOR; AGGRESSION; ANXIETY; ARTHRALGIA; ARTICLE; COMPLEX PARTIAL SEIZURE; DOG DISEASE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EVENING DOSAGE; LICKING; MALE; MORNING DOSAGE; NEUROLOGIC EXAMINATION; NONHUMAN; RELAPSE; URINALYSIS;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; DIPTERA; DOG DISEASES; DOGS; ELECTRODIAGNOSIS; ELECTROENCEPHALOGRAPHY; EPILEPSY, COMPLEX PARTIAL; MALE; NEUROPROTECTIVE AGENTS; SESQUITERPENES;

EID: 67849103549     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.06.011     Document Type: Article

References (37)

1. Hewson C.J., Luescher U.A., Parent J.M., Conlon P.D., and Ball R.O. Efficacy of clomipramine in the treatment of canine compulsive disorder. J Am Vet Med Assoc 213 (1998) 1760-1766
2. Holliday T.A., and Williams D.C. Interictal paroxysmal discharges in the electroencephalogram of the epileptic dog. Clin Tech Small Anim Pract 13 (1998) 132-143
3. Licht B.G., Licht M.H., Harper K.M., et al. Clinical presentation of naturally occurring canine seizures: similarities to human seizures. Epilepsy Behav 3 (2002) 460-470
4. Berendt M., and Gram L. Epilepsy and seizure classification in 63 dogs: an appraisal of veterinary epilepsy terminology. J Vet Intern Med. 13 (1999) 14-20
5. Breitschwerdt E.B., Breazile J.W., and Broadhurst J.J. Clinical and electroencephalographic findings associated with ten cases of suspected limbic epilepsy in the dog. J Am Hosp Assoc 15 (1979) 37-50
6. Dodman N.H., Knowles K.E., Shuster L., Moon-Fanelli A.A., Tidwell A.S., and Keen C.L. Behavioral changes associated with suspected complex partial seizures in Bull Terriers. J Am Vet Med Assoc 208 (1996) 688-691
7. Flink R., Pedersen B., Guekht A.B., et al. Guidelines for the use of EEG methodology in the diagnosis of epilepsy. Acta Neurol Scand 106 (2002) 1-7
8. Srenk P., and Jaggy A. Interictal electroencephalographic findings in a family of golden retrievers with idiopathic epilepsy. J Small Anim Pract 37 (1996) 317-321
9. Jeserevics J., Viitmaa R., Cizinauskas S., and Sainio K. Electroencephalography findings in healthy and Finnish Spitz dogs with epilepsy: visual and background quantitative analysis. J Vet Intern Med 21 (2007) 1299-1306
10. Kathmann I., Jaggy A., Busato A., Bartschi M., and Gaillard C. Clinical and genetic investigations of idiopathic epilepsy in the Bernese mountain dog. J Small Anim Pract 40 (1999) 319-325
11. Podell M., and Fenner W.R. Bromide therapy in refractory canine idiopathic epilepsy. J Vet Intern Med 7 (1993) 318-327
12. Trepanier L.A., Van Schoick A., Schwark W.S., and Carrillo J. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996). J Am Vet Med Assoc 213 (1998) 1449-1453
13. Govendir M., Perkins M., and Malik R. Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent. Aust Vet J 83 (2005) 602-608
14. Platt S.R., Adams V., Garosi L.S., et al. Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Vet Rec 159 (2006) 881-884
15. Podell M. Antiepileptic drug therapy. Clin Tech Small Anim Pract 13 (1998) 185-192
16. Volk H.A., Matiasek L.A., Feliu-Pascual A.L., Platt S., and Chandler K.E. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. Vet J 176 (2008) 310-319
17. Gaskill C.L., and Cribb A.E. Pancreatitis associated with potassium bromide/phenobarbital combination therapy in epileptic dogs. Can Vet J 41 (2000) 555-558
18. Dayrell-Hart B., Steinberg S.A., VanWinkle T.J., and Farnbach G.C. Hepatotoxity of phenobarbital in dogs: 18 cases (1985-1989). J Am Vet Med Assoc 199 (1991) 1060-1066
19. Yohn S.E., Morrison W.B., and Sharp P.E. Bromide toxicosis (bromism) in a dog treated with potassium bromide for refractory seizures. J Am Vet Med Assoc 201 (1992) 468-470
20. March P.A., Podell M., and Sams R.A. Pharmacokinetics and toxicity of bromide following high-dose oral potassium bromide administration in healthy Beagles. J Vet Pharmacol Ther 25 (2002) 425-432
21. Tang X.C., and Han Y.F. Pharmacological profile of Huperzine A, a novel acetylcholinesterase inhibitor from Chinese herb. CNS Drug Rev 5 (1999) 281-300
22. Lallement G., Veryret J., Masqueliez C., Aubriot S., Burckhart M.F., and Baubichon D. Efficacy of Huperzine A in preventing soman-induced seizures, neuropathological changes and lethality. Fundam Clin Pharm 11 (1997) 387-394
23. Tonduli L.S., Testylier G., Masqueliez C., Lallement G., and Monmaur P. Effects of Huperzine A used as pre-treatment against soman-induced seizures. Neurotoxicology 22 (2001) 29-37
24. Schachter SC, White HS, Stables J. Huperzine A. In: Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS, editors. Conference review: Progress report on new antiepileptic drugs. A summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res 2009;83:20.
25. McLean M.J., Gupta R.C., Dettbarn W.D., and Wamil A.W. Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol Appl Pharmacol 112 (1992) 95-103
26. Deutsch S.I., Mastropaolo J., Riggs R.L., and Rosse R.B. The antiseizure efficacies of MK-801, phencyclidine, ketamine, and memantine are altered selectively by stress. Pharmacol Biochem Behav 58 (1997) 709-712
27. Kohl B.K., and Dannhardt G. The NMDA receptor complex: a promising target for novel antiepileptic strategies. Curr Med Chem 8 (2001) 1275-1289
28. Tang X.-C., De Sarno P., Sugaya K., and Giacobini E. Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat. J Neurosci Res 24 (1989) 276-285
29. Chu D., Liu W., Li Y., Li P., Gu J., and Liu K. Pharmacokinetics of huperzine A in dogs following single intravenous and oral administrations. Planta Med 72 (2006) 552-555
30. Raffa R.B., and Friderichs E. The basic science aspect of tramadol hydrochloride. Pain Rev 3 (2000) 249-271
31. Gasse C., Derby L., Vasilakis-Scaramozza C., and Jick M.D. Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy 20 (2000) 629-634
32. Gardner J.S., Blough D., Drinkhard C.R., et al. Tramadol and seizures: a surveillance study in a managed care population. Pharmacotherapy 20 (2000) 1423-1431
33. Rendon R.A., Shuster L., and Dodman N.H. The effect of the NMDA receptor blocker, dextromethorphan, on cribbing in horses. Pharmacol Biochem Behav 68 (2001) 49-51
34. Dodman N.H., Shuster L., Nesbitt G., et al. The use of dextromethorphan to treat repetitive self-directed scratching, biting, or chewing in dogs with allergic dermatitis. J Vet Pharmacol Therap 27 (2004) 99-104
35. Poyurovsky M., Weizman R., Weizman A., and Koran L. Memantine for treatment-resistant OCD. Am J Psychiatry 162 (2005) 2191-2192
36. Pasquini M., and Biondi M. Memantine augmentation for refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1173-1175
37. Maurer B., and Dodman N.H. Animal behavior case of the month. J Am Vet Med Assoc 231 (2007) 536-539